Medline (NASDAQ:MDLN) Stock: Insider Private Ltd Gic Sells 2,570,999 Shares

Key Points

• Major shareholder Private Ltd GIC sold 2.57 million Medline shares for approximately $90.9 million at an average price of $35.35, reducing its ownership by 11.28% to 20.23 million shares.
• Medline shares opened at $35.55, down 0.7%, while the company reported quarterly EPS of $0.50, beating the $0.32 consensus estimate, on $7.68 billion in revenue.
• Product-quality concerns and related investor investigations remain an overhang, although analysts maintain a “Moderate Buy” consensus with an average price target of $46.88.

Medline (NASDAQ:MDLN - Get Free Report) major shareholder Private Ltd Gic sold 2,570,999 shares of the company's stock in a transaction that occurred on Friday, October 2nd. The shares were sold at an average price of $35.35, for a total value of $90,884,814.65. Following the completion of the sale, the insider owned 20,231,483 shares in the company, valued at approximately $715,182,924.05. This represents a 11.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Large shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.

Private Ltd Gic also recently made the following trade(s):

• On Tuesday, October 6th, Private Ltd Gic sold 7,183,013 shares of Medline stock. The stock was sold at an average price of $35.05, for a total value of $251,764,605.65.
• On Tuesday, October 6th, Private Ltd Gic sold 2,088,987 shares of Medline stock. The shares were sold at an average price of $35.05, for a total value of $73,218,994.35.
• On Monday, October 5th, Private Ltd Gic sold 1,688,690 shares of Medline stock. The shares were sold at an average price of $35.78, for a total value of $60,421,328.20.
• On Friday, October 2nd, Private Ltd Gic sold 7,146,941 shares of Medline stock. The shares were sold at an average price of $34.33, for a total transaction of $245,354,484.53.
• On Friday, August 14th, Private Ltd Gic sold 100,000 shares of Medline stock. The shares were sold at an average price of $35.80, for a total value of $3,580,000.00.
• On Thursday, August 13th, Private Ltd Gic sold 1,500,000 shares of Medline stock. The shares were sold at an average price of $35.80, for a total value of $53,700,000.00.
• On Friday, August 7th, Private Ltd Gic sold 590,284 shares of Medline stock. The shares were sold at an average price of $35.58, for a total value of $21,002,304.72.
• On Thursday, August 6th, Private Ltd Gic sold 271,994 shares of Medline stock. The shares were sold at an average price of $35.33, for a total value of $9,609,548.02.
• On Wednesday, August 5th, Private Ltd Gic sold 1,976,618 shares of Medline stock. The stock was sold at an average price of $35.60, for a total value of $70,367,600.80.

Medline Trading Down 0.7%

NASDAQ MDLN opened at $35.55 on Wednesday. The company has a market cap of $46.74 billion and a PE ratio of 45.00. The company has a current ratio of 4.33, a quick ratio of 2.61 and a debt-to-equity ratio of 0.66. Medline has a 12 month low of $31.49 and a 12 month high of $50.88. The stock has a 50 day moving average of $35.11 and a 200-day moving average of $38.55.

Medline (NASDAQ:MDLN - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.32 by $0.18. The firm had revenue of $7.68 billion for the quarter. On average, equities research analysts anticipate that Medline will post 1.51 EPS for the current fiscal year.

Trending Headlines about Medline

Here are the key news stories impacting Medline this week:

• Positive Sentiment: Medline announced that it will release third-quarter 2026 results before the market opens on November 4, followed by a conference call and webcast. The report could provide investors with updates on product-quality matters, demand, margins, and the company’s outlook. Medline third-quarter 2026 results announcement
• Neutral Sentiment: Pomerantz, Kaplan Fox, Kirby McInerney, and Bleichmar Fonti & Auld announced investigations related to Medline’s disclosures about manufacturing and product quality following a significant share-price decline. These announcements are largely investor-solicitation notices, and the articles do not establish wrongdoing or indicate that a lawsuit has been filed. Pomerantz Medline investor alert
• Negative Sentiment: Major shareholder Private Ltd GIC sold 2.09 million Medline shares for approximately $73.2 million on October 6 at an average price of $35.05, reducing its position by 11.27%. The shareholder also sold 1.69 million shares for about $60.4 million on October 5, cutting its holdings by 8.35%. The combined sales may weigh on sentiment because they signal insider-level selling and increase near-term supply, although the filings do not give a reason for the transactions. SEC ownership filing
• Negative Sentiment: The reported product-quality concerns and resulting securities investigations raise uncertainty around potential recalls, regulatory scrutiny, litigation costs, and damage to Medline’s reputation. Until the company provides additional details, these risks are likely to remain an overhang on MDLN.

Institutional Trading of Medline

Institutional investors and hedge funds have recently made changes to their positions in the stock. Janus Henderson Group PLC raised its position in Medline by 8.4% during the first quarter. Janus Henderson Group PLC now owns 11,451,861 shares of the company's stock valued at $506,546,000 after purchasing an additional 887,240 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of Medline by 233.3% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 5,000,000 shares of the company's stock valued at $222,500,000 after acquiring an additional 3,500,000 shares during the last quarter. Artisan Partners Limited Partnership purchased a new stake in Medline during the 4th quarter valued at about $192,847,000. Bessemer Group Inc. boosted its holdings in Medline by 39,404.0% during the 1st quarter. Bessemer Group Inc. now owns 3,504,006 shares of the company's stock valued at $155,929,000 after acquiring an additional 3,495,136 shares during the period. Finally, Capital World Investors bought a new stake in Medline in the fourth quarter valued at approximately $142,446,000.

Wall Street Analyst Weigh In

MDLN has been the topic of several analyst reports. Weiss Ratings raised Medline from a "sell (d)" rating to a "sell (d+)" rating in a report on Thursday, August 6th. Truist Financial cut their target price on Medline from $56.00 to $47.00 and set a "buy" rating on the stock in a report on Thursday, August 6th. UBS Group reduced their price target on shares of Medline from $45.00 to $43.00 and set a "buy" rating for the company in a report on Friday, September 25th. Robert W. Baird set a $42.00 price target on Medline in a research report on Thursday, August 6th. Finally, Tigress Financial dropped their price objective on Medline from $62.00 to $55.00 and set a "buy" rating on the stock in a research note on Tuesday, August 11th. Two analysts have rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, five have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $46.88.

Medline Company Profile

Medline Industries, Inc is a healthcare company that manufactures and distributes medical supplies, clinical products and equipment to hospitals, health systems, physician practices, long-term care facilities, surgery centers and other healthcare providers. Its offerings are designed to support patient care, surgical procedures, infection prevention and healthcare facility operations.

The company's product portfolio includes surgical instruments and supplies, exam gloves and protective apparel, wound care products, patient-care items, respiratory and monitoring equipment, laboratory supplies, durable medical equipment and products for environmental and facility management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.